HR. 8205Reported

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Chamber
House
Sponsor
Mike QuigleyMike QuigleyHouse • District 5
Introduced
2026-04-06
Impact Score
43
Limited
Momentum
57
Active
Summary
Extend authorization for accelerated access activities and related therapeutic development for amyotrophic lateral sclerosis treatments
What this does
  • Extend ALS therapy authorization
Latest action
2026-05-21 — Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.
Full Text (PDF)Amendments
View on Congress.gov